Tuberculosis, caused by Mycobacterium tuberculosis infection, is an infectious disease that is responsible for the deaths of around two million people a year.
Tuberculosis, caused by Mycobacterium tuberculosis infection, is an infectious disease that is responsible for the deaths of around two million people a year. 1) Aggravation of tuberculosis is evaded by host immune systems, even if infection is concluded completely. However, a small population of bacilli changes their phenotype into dormant state in the granuloma formed by immune cells. Then, the bacilli keep their ability to resume growth and aggravate disease as a result of deterioration of immune systems. This unique property also relates to resistance against conventional anti-tuberculosis drugs such as isoniazid.
2) Therefore, the lead compounds, which are effective to M. tuberculosis in both active state and dormant state, are urgently needed.
Although physiology of the latent M. tuberculosis infection is still unclear, hypoxic condition was found to induce dormant state of Mycobacterium sp., which has a drug susceptibility profile resembling that of the latent M. tuberculosis. [3] [4] [5] Recently, we have established a screening system for anti-dormant mycobacterial substances, and then, re-discovered halicyclamine A from a marine sponge of Haliclona sp. 05A08. 6) In the continuous screening from marine organisms, we isolated a new compound named 22-hydroxyhaliclonacyclamine B (1) together with two known alkaloids, haliclonacyclamine A (2) and B (3), were isolated from an Indonesian marine sponge of Haliclona sp. as anti-dormant mycobacterial compounds. In this paper, the structure elucidation of 22-hydroxyhaliclonacyclamine B (1) and the anti-mycobacterial activity of haliclonacyclamines are presented.
Results and Discussion
The MeOH extract of the dried marine sponge (1 kg) of Haliclona sp. 01D53, which was collected in 2001 at Indonesia, showed anti-microbial activity against Mycobacterium smegmatis under both aerobic condition and hypoxic condition inducing dormant state. On the guidance of bioassay, the MeOH extract was partitioned into a water-EtOAc mixture. The aqueous phase was further partitioned with n-BuOH.
The n-BuOH soluble portion (5.5 g) was fractionated by Diaion HP-20 column chromatography, Sephadex LH-20 column chromatography, ODS column chromatography, MCI gel column chromatography, and HPLC using COSMOSIL Sugar-D column to afford 22-hydroxyhaliclonacyclamine B (1, 3.5 mg, 0.06% yield from the n-BuOH soluble portion), haliclonacyclamine A (2, 5 mg, 0.09%), and haliclonacyclamine B (3, 10 mg, 0.17%) (Fig. 1) . Compounds 2 and 3 were identified by physico-chemical properties, ESI-TOF-MS and 2D-NMR analysis and comparison with authentic spectral data. 7) 22-Hydroxyhaliclonacyclamine B (1) was obtained as colorless solid. The ESI-TOF-MS of 1 showed a quasi-molecular ion peak [MϩH] ϩ at m/z 485, which was larger than that of 3 by 16 amu, and the molecular formula was determined as C 32 49.8, 68.7, 69.0, 57.0, 74.0), and an oxymethine carbon (d C 71.5) were closely similar to those of 3, except for the signals adjacent to C-22. The two partial structures (A, B) in 1 were revealed by COSY and HSQC analysis (Fig. 2) . And, the connectivity of these partial structures was figured out on the basis of the HMBC correlations as shown in Fig. 2 . All the proton-and carbon-signals were assigned as shown in Table  1 , and the planar structure of 1 was elucidated as shown in Fig. 2 . The relative stereostructure of 1 was revealed by the ROESY correlations between H-5a, H-3 and H-1a; H-3, H-2, H-7 and H-9; H-7 and H-6b; H-10a and H-6a; as shown in Fig. 3 . For the scarcity of the isolated amount, the stereochemistry of the 22-hydroxyl group in 1 was not investigated.
The dormant M. tuberculosis was highly resistant against isoniazid, which is conventional drug and inhibits inhA of type II fatty acid biosynthetic enzyme. [3] [4] [5] 8) The MIC values of isoniazid against M. smegmatis and M. bovis Bacille de Calmette et Guérin (BCG) were 2.5 and 0.03 mg/ml under aerobic condition, respectively. While, the MIC values of isoniazid against these strains were more than 25 mg/ml under nitrogen atmosphere containing 0.2% oxygen. On the other hand, the MIC values of haliclonacyclamines A (2) and B (3) were 2.5 and 1.0 mg/ml against M. smegmatis and M. bovis BCG under both aerobic and hypoxic conditions, respectively (Table 2 ). These results indicated that compounds 2 and 3 were effective against Mycobacterium sp. in both actively growing state and dormant state. On the other hand, 22-hydroxyhaliclonacyclamine B (1) showed weaker antimycobacterial activity with MICs in the range of 12.5-50 mg/ml. Therefore, the 22-hydroxy group in 1 reduced anti-mycobacterial activity. Moreover, to examine whether the anti-mycobacterial activity of haliclonacyclamines is bactericidal or bacteriostatic, colony forming unit (CFU) assay was executed using compound 3 in both aerobic and hypoxic conditions. As shown in Fig. 4 , the CFU of M. bovis at Flores Island, Indonesia, was extracted with MeOH. The MeOH extract (100 g), which exhibited anti-mycobacterial activity against M. smegmatis under both aerobic and hypoxic conditions with MIC 100 mg/ml, was partitioned into a water-EtOAc mixture (1 : 1). The aqueous phase was further partitioned with n-BuOH. The n-BuOH soluble portion (5.5 g, MIC 6.0 mg/ml) was fractionated by Diaion HP-20 column chromatography to give an active MeOH containing 0.1% TFA eluate, which was further separated by Sephadex LH-20 column (MeOH) to afford an active fraction (1.5 g, MIC 6.0 mg/ml). The active fraction was then separated by ODS 10) The mycobacterial bacilli were grown in Middlebrook 7H9 broth at 37°C under nitrogen atmosphere containing 0.2% oxygen until the optical density reached 0.8 at 600 nm. Then, the bacilli were inoculated to the 96-well plate in the same density as the aerobic condition and incubated at 37°C under nitrogen atmosphere containing 0.2% oxygen for 96 h (for M. smegmatis) or for 14 d (for M. bovis BCG). After incubation, 50 ml of MTT solution (0.5 mg/ml) was added into each well and incubated at 37°C for additional 12 h under aerobic or hypoxic conditions. The optical density at 560 nm was measured to determine MIC value.
Bactericidal Effect of Haliclonacyclamine B (3) against M. bovis BCG under Both Aerobic and Hypoxic Conditions The M. bovis BCG were grown in Middlebrook 7H9 broth at 37°C under aerobic condition or nitrogen atmosphere containing 0.2% oxygen until the optical density reached 0.8 at 600 nm. The culture of M. bovis BCG in Middlebrook 7H9 broth was adjusted to 1ϫ10 6 CFU/ml, and then compound 3 (5.0 mg/ml) was added. The 100 ml of portion was collected at each time point, and serial diluted culture was plated on the Middlebrook 7H10 agar to measure CFU. Number of colony was counted after 4 weeks incubation. Vol. 57, No. 10 
